AAAAAA

   
Results: 1-12 |
Results: 12
INSULIN-TREATMENT INHIBITS PAI-1 PRODUCTION IN NIDDM PATIENTS WITH ENDOTHELIAL DYSFUNCTION
Authors: GALAJDA P BALAZ D MARTINKA E MOKAN M KUBISZ P
Citation: P. Galajda et al., INSULIN-TREATMENT INHIBITS PAI-1 PRODUCTION IN NIDDM PATIENTS WITH ENDOTHELIAL DYSFUNCTION, Clinical and applied thrombosis/hemostasis, 4(4), 1998, pp. 250-252
PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) LEVELS ARE DECREASED IN NIDDM PATIENTS TREATED WITH INSULIN
Authors: GALAJDA P MARTINKA E STASKO J MOKAN M KUBISZ P
Citation: P. Galajda et al., PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) LEVELS ARE DECREASED IN NIDDM PATIENTS TREATED WITH INSULIN, Clinical and applied thrombosis/hemostasis, 4(2), 1998, pp. 138-139
A REDUCTION OF PROTEIN-SPECIFIC MOTIONS IN CO-LIGATED MYOGLOBIN EMBEDDED IN A TREHALOSE GLASS
Authors: CORDONE L GALAJDA P VITRANO E GASSMANN A OSTERMANN A PARAK F
Citation: L. Cordone et al., A REDUCTION OF PROTEIN-SPECIFIC MOTIONS IN CO-LIGATED MYOGLOBIN EMBEDDED IN A TREHALOSE GLASS, European biophysics journal, 27(2), 1998, pp. 173-176
PAI-1 LEVELS ARE DECREASED BY INSULIN-TREATMENT IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS WITH ENDOTHELIAL DYSFUNCTION
Authors: GALAJDA P BALAZ D MARTINKA E SUTARIK C KUBISZ P MOKAN M
Citation: P. Galajda et al., PAI-1 LEVELS ARE DECREASED BY INSULIN-TREATMENT IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS WITH ENDOTHELIAL DYSFUNCTION, Diabetologia, 41, 1998, pp. 1273-1273
INSULIN-TREATMENT DECREASES PAI-1 LEVELS IN NIDDM PATIENTS WITH ENDOTHELIAL DYSFUNCTION
Authors: GALAJDA P BALAZ D STASKO J MOKAN M KUBISZ P
Citation: P. Galajda et al., INSULIN-TREATMENT DECREASES PAI-1 LEVELS IN NIDDM PATIENTS WITH ENDOTHELIAL DYSFUNCTION, British Journal of Haematology, 102(1), 1998, pp. 133-133
EFFECTS OF ERYTHROPOIETIN, GM-CSF AND G-CSF ON PROLIFERATION AND RELEASE OF ENDOTHELIAL MARKERS IN HUVEC CULTURE
Authors: STASKO J DROUET L SORIA C CAEN J GALAJDA P KUBISZ P
Citation: J. Stasko et al., EFFECTS OF ERYTHROPOIETIN, GM-CSF AND G-CSF ON PROLIFERATION AND RELEASE OF ENDOTHELIAL MARKERS IN HUVEC CULTURE, Thrombosis and haemostasis, 1997, pp. 452-452
PAI-1 LEVELS ARE DECREASED BY INSULIN-TREATMENT IN NIDDM
Authors: GALAJDA P MARTINKA E BALAZ D KERNY J STASKO J MOKAN M KUBISZ P
Citation: P. Galajda et al., PAI-1 LEVELS ARE DECREASED BY INSULIN-TREATMENT IN NIDDM, Thrombosis and haemostasis, 1997, pp. 1464-1464
ENDOTHELIAL MARKERS IN DIABETES-MELLITUS
Authors: GALAJDA P MARTINKA E MOKAN M KUBISZ P
Citation: P. Galajda et al., ENDOTHELIAL MARKERS IN DIABETES-MELLITUS, Thrombosis research, 85(1), 1997, pp. 63-65
HALIDE ION-BINDING BY BACTERIORHODOPSIN AT LOW PH
Authors: SZARAZ S KELEMEN L GALAJDA P ORMOS P
Citation: S. Szaraz et al., HALIDE ION-BINDING BY BACTERIORHODOPSIN AT LOW PH, Progress in Biophysics and Molecular Biology, 65, 1996, pp. 406-406
ENDOGENOUS DIGITALIS-LIKE SUBSTANCES IN DIABETIC SUBJECTS
Authors: MARTINKA E GALAJDA P MOKAN M
Citation: E. Martinka et al., ENDOGENOUS DIGITALIS-LIKE SUBSTANCES IN DIABETIC SUBJECTS, Diabetologia, 39, 1996, pp. 670-670
FIBRINOLYTIC PARAMETERS IN RELATION TO C-PEPTIDE AND ENDOGENOUS DIGITALIS-LIKE SUBSTANCES IN DIABETIC SUBJECTS
Authors: MOKAN M MARTINKA E GALAJDA P KUBISZ P
Citation: M. Mokan et al., FIBRINOLYTIC PARAMETERS IN RELATION TO C-PEPTIDE AND ENDOGENOUS DIGITALIS-LIKE SUBSTANCES IN DIABETIC SUBJECTS, Diabetologia, 39, 1996, pp. 904-904
DIGOXIN-LIKE IMMUNOACTIVITY AND GLUCOSE-TOLERANCE IN PREGNANCY
Authors: MARTINKA E MATUSEK J OCHODNICKY M KVETENSKY J GALAJDA P MOKAN M
Citation: E. Martinka et al., DIGOXIN-LIKE IMMUNOACTIVITY AND GLUCOSE-TOLERANCE IN PREGNANCY, Diabetes, nutrition & metabolism, 6(4), 1993, pp. 189-194
Risultati: 1-12 |